Clinical Trials
- Children's Health, Diabetes
CGM Intervention in Teens and Young Adults With Type 1 Diabetes (T1D) (CITY)
- Ages14 years - 24 years
- GenderBoth
- Diabetes
Hybrid Closed Loop Therapy and Verapamil for Beta Cell Preservation in New Onset Type 1 Diabetes (CLVer) A Proof-of-Concept Study
- Ages7 years - 17 years
- GenderBoth
- Diabetes
Hydroxychloroquine in Individuals At-risk for Type 1 Diabetes Mellitus (TN-22)
- Ages3 years and older
- GenderBoth
- Diabetes, Endocrine System, Brain, Spinal Cord & Nervous System
Impact of Hypoglycemia on Brain Ketone and Neurotransmitter Metabolism in Type 1 DM
- Ages18 years and older
- GenderBoth
- Diabetes
Metabolic Changes Induced by a Very Low Carbohydrate Diet in Youth With Type 1 Diabetes
- Ages12 years - 24 years
- GenderBoth
- Children's Health, Diabetes, Endocrine System
Pathway to Prevention Study
- Ages1 year - 45 years
- GenderBoth
- Children's Health, Diabetes
Safety Evaluation of the Advanced Hybrid Closed Loop (AHCL) System
- Ages7 years - 75 years
- GenderBoth
- Diabetes
TrialNet TOPPLE Study for People with Type 1 Diabetes
- Ages18 years - 45 years
- GenderBoth